[1]
2025. Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach. Asian Journal of Diabetology. 25, 1 (Aug. 2025), 7–21. DOI:https://doi.org/10.59793/0vmn8208.